NCT07403175Completed
Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides in Migraine
Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides on Severity, Disability and Quality of Life in Patients With Migraine
Source: ClinicalTrials.gov · Last updated 11 Feb 2026
Brief summary (registry, in English)
This study was conducted to evaluate the synergistic impact of postural correction interventions and sustained natural apophyseal glides on severity, quality of life and disability in patients with migraine.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 44 (actual)
- First submitted
- 4 Feb 2026
- Start date
- 10 Jan 2025
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Riphah International University
- Diseases
- Migraine
- NCT number
- NCT07403175
What you commit to
- Study type: Interventional
- Participants enrolled: 44
- From 10 Jan 2025 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous neck/head trauma from \>2 years.
- Ongoing radiotherapy, chemotherapy, steroid therapy, or anticoagulants.
Other illness
- Spinal infections/diseases e.g. Tumor, TB spine
- Any history of neurological disorders e.g. stroke, abcess, haemorrhage, haematoma
- Upper motor neuron disease, cervical stenosis, and metabolic diseases in bone and joint.
- Psychiatric diseases such as phobia/obsession and depression.
Age
- Any neck/head surgery \>2 years
Other
- Participants having active migraine and other headache types e.g. Cluster headache.
- Severe Osteoporosis
- Pregnancy
Who the study is looking for
- A diagnosis of episodic migraine made by the primary investigator according to ICHD-2.
- Symptoms must include at least two of the following: Unilateral pain, Pulsating/throbbing pain, Nausea, Vomiting, Photophobia/phonophobia.
- Participants should be full time employees or Desktop users.
- Participants have a history of at least migraine \>4 days per month.
- Participants having history of migraine lasting from 4-72 hours
- Age group between 22 and 45 years.
- Both gender male and female.
- Participants who agree to cut-off any pharmacological treatment during study.
- Participants should have an average score between 3-6 on pain intensity scale.
Age in the registry: 22 years to 45 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abdul Ahaad Hospital, Sialkot Coordinator of this site? Confirm its status | Sialkot | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.